Charles River lays out $293M to snap up viral vector specialist Vigene, its 2nd M&A deal this year

A few short months after Charles River Laboratories acquired Cognate BioServices, the company is folding yet another CDMO into its cell and gene network, signing more than $1 billion in M&A outlays so far this year.